Navigation Links
Personalized Medicine: Conference Provides Update on Progress and Prospects
Date:8/30/2010

SAN FRANCISCO, Aug. 30 /PRNewswire/ -- Thanks to the accelerating pace of scientific discovery in life sciences, coupled with our ability to process and analyze enormous amounts of genetic information, the field of personalized medicine has evolved.

"Healthcare is now shifting towards predictive and preventative care utilizing diagnostics that allow physicians to follow the course of a disease, evaluate which therapeutic regimes are most effective, and determine long-term susceptibility and recurrence," said G. Steven Burrill, CEO of Burrill & Company. "As diseases are better understood at a molecular level, the promise of personalized medicine is becoming a reality.

"In addition, personalized medicine now extends beyond targeted therapeutics and diagnostics to encompass a 'consumer digital health' world that includes areas such as: personal health record management, health IT, wellness and nutrition," added Burrill, "and we will be providing delegates with an update to what this means for personalized medicine."

The 6th Annual Burrill Personalized Medicine conference, to be held in San Francisco, September 27-28, 2010, will update attendees on where we are today in the context of a turbulent, challenging economy, and a "post healthcare reform environment."  The two-day meeting will bring together stakeholders from across the value chain of personalized medicine for a fascinating set of "conversations" on key topics including: "Has "Healthcare Reform" accelerated or decelerated the move to a more personalized medicine world?" "The Translational Challenge: Building the Scientific Infrastructure for Personalized Medicine" and "What Will it Take to Get Patients to Believe in Personalized Medicine and Can Medicine Deliver on this Promise?"

The 6th Annual Burrill Personalized Medicine conference, presented this year in association with the Duke Institute for Genome Sciences and Policy, has become a "must attend" event providing an annual window into the progress of personalized medicine and the challenges and opportunities that this new paradigm presents.

Further details on the agenda may be obtained from: http://www.burrillandco.com/personalized_medicine_2010/


'/>"/>
SOURCE Burrill & Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medigene Appointed Exclusive Greek Licensee for GeneMedRx Personalized Prescribing Software
2. Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
3. MediSapiens Gets $ 1 Million for Worlds First Personalized Cancer Medicine Software
4. New Hip Implant Provides Personalized Fit
5. Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine
6. Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
7. $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers
8. Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated
9. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
10. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
11. Personalized Medicine Killer Apps Will Transform Care Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):